An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...
Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...
Resistant diabetic macular edema may necessitate transitioning from one intravitreal pharmacotherapy to another when the edema is persistent — a practice sometimes undertaken in clinical management.
(HealthDay News) – Treatment with a thiazolidinedione is associated with an increased one- and 10-year risk of diabetic macular edema (DME) in patients with type 2 diabetes, according to a study ...
Peter Salgo, MD: One of the things about knowing your A1c is now that you know it, and if it’s not good, let’s fix it. That being said, let’s take a look at this in the setting of diabetic retinopathy ...
On the innovative side, there are ongoing trials for combining therapies—anti-VEGF plus steroids or laser—to get better and faster outcomes. AI-assisted retina exams are enabling doctors to detect DME ...
Kenneth J. Snow, MD, MBA: We put a significant value on preventing disease progression. We know that diabetes is a chronic illness and the complications come about over the course of time, and we ...
Credit: Regeneron. Eylea HD is supplied as a sterile, aqueous solution for intravitreal injection in a single-dose vial containing 8mg of aflibercept. The Food and Drug Administration (FDA) has ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Brolucizumab ...
DelveInsight's,“ Diabetic Macular Edema Pipeline Insight 2025 ” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback